Przejdź do treści

Filtry

Dane naukowe

Podręcznik/instrukcje

Aktualności

Short courses of antibiotics for children and adults with bronchiectasis

Także dostęne w

There is a paucity of evidence to conclude whether short courses of antibiotics (i.e. less than or equal to four weeks) are equivalent or superior to placebo in the treatment of stable or exacerbation state bronchiectasis. One single study showed some benefit of short-course inhaled antibiotics over placebo, in terms of microbiological response and subjective improvement in medical condition, although this was balanced against an increase in adverse effects and antimicrobial resistance in the treatment group. Given the potential benefits of shorter duration antibiotic therapy in bronchiectasis, further RCTs are clearly needed to answer this important question.

Wprowadzenie

Bronchiectasis is an important cause of respiratory morbidity in both developing and developed countries. Antibiotics are considered standard therapy in the treatment of this condition but it is unknown whether short courses (four weeks or less) are efficacious.

Cele

To determine whether short courses of antibiotics (i.e. less than or equal to four weeks) for treatment of acute and stable state bronchiectasis, in adults and children, are efficacious when compared to placebo or usual care.

Metody wyszukiwania badań

The Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library), MEDLINE, EMBASE, OLDMEDLINE, CINAHL, AMED and PsycINFO and handsearching of respiratory journals and meeting abstracts were performed by the Cochrane Airways Group up to February 2011.

Kryteria doboru badań

Only randomised controlled trials were considered. Adults and children with bronchiectasis (defined clinically or radiologically) were included. Patients with cystic fibrosis were excluded.

Zbieranie i analiza danych

Two review authors independently reviewed the titles, abstracts and citations to assess eligibility for inclusion. Only one study fulfilled the inclusion criteria and thus meta-analysis could not be performed.

Główne wyniki

The single eligible study showed a small benefit, when compared to placebo, of four weeks of inhaled antibiotic therapy in adults with bronchiectasis and pseudomonas in their sputum. There were no studies in children and no studies on oral or intravenous antibiotics.

Wnioski autorów

There is insufficient evidence in the current literature to make reasonable conclusions about the efficacy of short course antibiotics in the management of adults and children with bronchiectasis. Until further evidence is available, adherence to current treatment guidelines is recommended.

Cytowanie
Wurzel D, Marchant JM, Yerkovich ST, Upham JW, Masters IBrent, Chang AB. Short courses of antibiotics for children and adults with bronchiectasis. Cochrane Database of Systematic Reviews 2022, Issue 4. Art. No.: CD008695. DOI: 10.1002/14651858.CD008695.pub2.

Używamy plików cookie

Używamy niezbędnych plików cookie, aby nasza strona mogła działać. Chcielibyśmy również ustawić opcjonalne pliki cookie do analizy, aby pomóc nam udoskonalić tę stronę. Nie będziemy ustawiać opcjonalnych plików cookie, chyba że je włączysz. Użycie tego narzędzia spowoduje ustawienie pliku cookie na Twoim urządzeniu, aby zapamiętać Twoje preferencje. W każdej chwili możesz zmienić swoje preferencje dotyczące plików cookie, klikając na link "Ustawienia plików cookie" znajdujący się w stopce każdej strony.
Bardziej szczegółowe informacje na temat używanych przez nas plików cookie można znaleźć na naszej stronieStrona plików cookies

Zaakceptuj wszystkie
Skonfiguruj